The effectiveness of methotrexate for the escape by salazosulfapyridine

Yakugaku Zasshi

Volumn 125, Issue 7, 2005, Pages 579-582

  Kawasaki, Yoichi ^a,b   Moriyama, Masahiro ^a   Shibata, Kazuhiko ^a,b   Gomita, Yutaka ^a,b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Disease modifying anti rheumatic drugs; Escape phenomenon; Methotrexate; Rheumatoid arthritis; Salazosulfapyridine

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; ECZEMA; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HUMAN; LIVER DISEASE; MALE; PARESTHESIA; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 25144493334     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.125.579     Document Type: Article

References (16)

1. Hochberg M. C., Scand. J. Rheumatol., 112, Suppl., 3-7 (1999).
2. Sokka T., Möttönen T., Hannonen P., Rheumatology, 39, 34-42 (2000).
3. Wolfe F., Sharp J., Arthritis Rheum., 41, 1571-1582 (1998).
4. Möttönen T., Hannonen P., Lerisalo-Repo M., Nissila M., Kantiainen H., Korpela M., Laasonen L., Julkunen H., Luukkainen R., Vuori K., Paimela L., Blafield H., Hakala M., Ilva K., Yli-Kerttula U., Puolakka K., Jarvinen P., Hakola M., Piirainen H., Ahonen J., Palvimaki I., Forsberg S., Koota K., Friman C., Lancet, 353, 1568-1573 (1999).
5. Takasugi K., Riumatika, 14, 283-291 (1995).
6. Kawasaki Y., Moriyama M., Shibata K., Gomita Y., Yakugaku Zasshi, 125, 293-297 (2005).
7. Oribe M., Mod. Physician, 20, 75-78 (2000).
8. Haagsma C. J., Vanrield P. L. C. M., De Rooij D. J. R. A. M., Vree T. B., Russel F. J., Van't hof M. A., Van De Putte L. B., Br. J. Rheumatol., 33, 1049-1055 (1994).
9. Maxime D., Bernard C., Alain C., Philippe G., Patrick O., Manfred S., Meusser S., Paimela L., Rolf R., Henning Z., Leirisalo-Repo M., Kristiina P., Ann. Rheum. Dis., 58, 220-225 (1999).
10. Aletaha D., Stamm T., Kapral T., Eberl G., Grisar J., Machold K. P., Smolen J. S., Ann. Rheum. Dis., 62, 944-951 (2003).
11. Kawasaki Y., Moriyama M., Shibata K., Gomita Y., J. Jpn. Soc. Hosp. Pharm., 41, 155-158 (2005).
12. Tanaka H., Iwakawa K., Yamamoto M., Yamazaki J., Nagashima M., Yoshino S., Riumatika, 27, 39-46 (2002).
13. Nagaoka S., Ohno M., Sekiguchi A., Clin. Rheumatol., 15, 220-226 (2003).
14. Mitsuhashi T., Mannami K., Clin. Rheumatol., 15, 130-135 (2003).
15. Kawasaki Y., Moriyama M., Shibata K., Gomita Y., J. Jpn. Soc. Hosp. Pharm., 41, 537-540 (2005).
16. Abe T., Takeuchi T., Itoh K., Koide J., Riumatika, 14, 135-139 (1995).